Archive for ADHD New Zealand
ADHD Medication: Strattera Funded in New Zealand
Posted by: | CommentsIt has just been reported that PHARMAC will be funding Strattera in New Zealand.
Strattera is also known as Atomoxetine – and is a non-stimulant for the treatment of ADHD.
Pharmac funding of Strattera will be `second line`, meaning that they will fund it if both of the stimulant medicines (i.e. ritalin and dexedrine) are not effective for ADHD for the individual, or cause significant side effects.
Concerta in New Zealand
Posted by: | CommentsPharmac has just announced that it will now cover the once daily Concerta for ADHD.
You can read the news release here.
Concerta is a once daily, long acting medication for ADHD.
Prior to this, Pharmac was only funding the generic Rubifen for ADHD, and occasionally it would cover the name brand Ritalin, as described here.
